Ozkan Yalkinoglou colchicine-vs-naproxen.htm.

Ozkan Yalkinoglou, Medical Director of ABX-CRO. Its first-in-human administration is the most significant and significant milestone in our corporate history. Cameron Durrant, Executive Chairman of Anavex colchicine-vs-naproxen.htm . Angelos Stergiou, Vice President of Clinical Development & Medical Affairs for Anavex. Dosing of at least 16 healthy volunteers is likely to be full in approximately 90 days. About the ANAVEX 2-73 Stage I Clinical Trial This Phase I medical trial is definitely a randomized, placebo-controlled study to primarily test ANAVEX 2-73 as a single, ascending oral dosage in healthful volunteers.